When tuberculosis hides where traditional tests can't reach
A Note from Dr. Agbaosi: This episode of Mystery Infection Files™️ is particularly meaningful to me because these three patients are part of a case series I published in the medical literature, in collaboration with my colleagues. Their stories represent real breakthroughs in how we diagnose tuberculosis when traditional methods fall short.
She couldn't produce sputum.
A simple request like "please cough into this cup so we can test what's in your lungs" was an impossible task.
This was our patient with confusion, weight loss, night sweats and a massive abscess lesion in her right upper lung on imaging.
Everything screamed TUBERCULOSIS.
But without sputum, without any respiratory secretions to culture, the diagnosis remained frustratingly out of reach.
She sat in respiratory isolation, day after day, while doctors tried to figure things out.
What was eating a hole through her lung?
Sometimes, the infectious "bug" doctors are desperately searching for is hiding in plain sight.
Three Patients, One Invisible Enemy
Let me tell you about three every day people whose lives intersected with tuberculosis in ways that traditional diagnostics couldn't capture.
Mrs. Clara : A woman with thyroid disease and a pituitary tumor, presenting with confusion and a massive pus pocket in her lungs. Unable to make sputum. Bronchoscopy not safe. Trapped in isolation with a diagnosis we suspected but couldn't prove.
Mr. Cornelius: A recent immigrant from Guinea with what appeared to be metastatic pancreatic cancer. Twenty pounds weight loss, profoundly fatigued, blood counts crashing. Advanced HIV with a CD4 count of just 15 cells, hardly any immunity left. A pancreatic mass that screamed "death" on imaging.
Mr. Collins: An Ethiopian native with a history of tuberculosis treated decades ago, now presenting with confusion and weakness. No fever, no night sweats, no cough. Absolute absence of the classic symptoms. But imaging noted nodules everywhere: lungs, liver, spleen, lymph nodes. Advanced HIV with CD4 count of 108.
Three patients.
Three different presentations.
One common theme.
Tuberculosis that traditional diagnostics struggled to find.
Here's the problem with diagnosing tuberculosis in complex patients:
You need tissue or fluid samples from sites where the bacteria are actively growing. For pulmonary TB, that means sputum, bronchoscopy samples, or lung biopsies. For extrapulmonary TB (aka TB outside the lungs), you need to biopsy the affected organs.
But what happens when:
The patient can't produce sputum?
Bronchoscopy can't be performed safely?
The TB has spread to multiple organs?
The patient is too sick for invasive procedures?
You need an answer NOW to start treatment and release from isolation?
Traditional diagnostics hit a wall.
Mrs. Clara: The Woman With Pus in her Lungs
She had every risk factor pointing to TB except one crucial element: she couldn't produce the specimen needed to prove it.
The cavitary lesion on her chest imaging was classic. The positive IGRA (interferon-gamma release assay) confirmed TB exposure. But without microbiological proof like stains or culture, starting long-term TB treatment would not be appropriate.
Several days passed in respiratory isolation while the confusion persisted.
Then came the Metagenomics (cfDNA) test from her blood: 684 molecules per 100 nanoliters of Mycobacterium tuberculosis.
Not a maybe. Not a possible. Not a suspected.
Definitive molecular proof that MTB DNA was circulating in her bloodstream.
Treatment for TB with "RIPE" therapy was started immediately. Eventually, bronchoscopy was performed and cultures grew drug-susceptible MTB, confirming what the metagenomics test had already told us.
She improved rapidly and completed treatment successfully.
Mr. Cornelius and The Cancer That Wasn't
What if you were told, you had metastatic pancreatic cancer.
Imaging confirmed a mass in his pancreas.
Swollen lymph nodes throughout his body.
Twenty pounds weight loss.
His blood counts free falling each day.
Then discovering he was HIV-positive with virtually no immune system left. An absolute CD4 count of 15, when normal is 500-1,200.
This reeks of end-stage disease. Multiple severely life-threatening conditions being diagnosed all at once.
But Metagenomics testing revealed something unexpected: Mycobacterium tuberculosis DNA in the bloodstream.
The "pancreatic cancer" was actually a tuberculous mass.
The lymph nodes everywhere was TB.
The pancytopenia was from TB in the bone marrow, which was later confirmed when bone marrow biopsy showed necrotizing granulomas packed with acid-fast bacilli.
Disseminated tuberculosis masquerading as metastatic cancer. 😳
RIPE therapy was started along with antiretroviral therapy and prophylaxis against opportunistic infections.
The response was remarkable:
repeat imaging showed the pancreatic mass had completely resolved.
No cancer.
Just tuberculosis that had spread everywhere because HIV had destroyed the immune system that normally keeps it contained.
Mr. Collins and The Ghost of TB Past
He overcame tuberculosis twenty years ago when he left Ethiopia.
Or so he thought.
Decades later, now diagnosed with advanced HIV and a CD4 count of 108, TB returned with a vengeance.
But not in the lungs with cough and fever.
Instead, it presented with confusion and weakness. Neurological symptoms that made no one think "tuberculosis."
Imaging revealed nodules in lungs, liver, spleen. Generalized lymphadenopathy.
This was disseminated disease.
A needle biopsy of a lymph node came back non-diagnostic. Not enough tissue 🙄.
Still No clear answer.
Until.....
Metagenomics (mNGS) testing detected Mycobacterium tuberculosis in his blood.
Treatment was started immediately!
A subsequent open lymph node biopsy confirmed necrotizing granulomas with acid-fast bacilli, and culture grew drug-susceptible MTB.
He improved, completed treatment, and continued on antiretroviral therapy.
The Metagenomics' Revolution in TB Diagnosis
Here's what makes mNGS testing revolutionary for tuberculosis:
It doesn't require tissue samples from the site of infection.
Let's sit on that for a minute :
You can't get sputum? Test the blood.
The bronchoscopy's too risky? Test the blood.
hmmm, how'bout extra-pulmonary TB in hard-to-reach places? Test the blood.
maybe, you need an answer before invasive procedures? Test the blood.
Mycobacterium tuberculosis DNA circulates in various body fluids — plasma, pleural fluid, urine, ascitic fluid.
When TB bacteria die or shed genetic material, that DNA floats freely in the bloodstream, detectable by next-generation sequencing.
The pathogen leaves a genetic fingerprint even when traditional cultures fail.
This Matters Especially Now!
Tuberculosis kills over 1.3 million people annually worldwide. It's one of the top infectious disease killers globally.
And in complex patients, like those with HIV, those who can't produce specimens, those with atypical presentations, traditional diagnostics often struggle.
Consider the barriers that mNGS testing overcomes:
Time: TB culture results can take weeks. mNGS results come back in days.
Specimen requirements: No need for sputum induction, bronchoscopy, or invasive biopsies as a first step.
Sensitivity in extra-pulmonary disease: Studies show mNGS has higher sensitivity than culture-based methods for TB outside the lungs.
Isolation duration: Earlier diagnosis means earlier treatment and potentially shorter isolation periods.
What Are The Limitations ?
Let's be honest, mNGS testing isn't perfect
Sensitivity varies: Ranging from 50-80% depending on the assay and sample type. It's not 100%.
Cost: More expensive than traditional testing, though prices are coming down.
Drug susceptibility: Unlike cultures, mNGS doesn't tell you if the TB strain is drug-resistant. You still need cultures for that.
Not yet in guidelines: Major TB diagnostic guidelines don't yet include mNGS as a standard recommendation.
But here's the critical point: In selected clinical scenarios such as these three patients, mNGS can be the difference between diagnostic confusion and definitive answers.
Better Tools, Better Decisions, Better Outcomes™️
These three cases prove a fundamental truth in modern medicine: better tools, helps clinicians make better decisions and leads to better outcomes for our patients.
Mrs. Clara got out of isolation faster and started effective therapy without waiting for bronchoscopy.
Mr. Cornelius avoided unnecessary cancer workup and got life-saving TB treatment .
Mr. Collins got diagnosed and treated despite atypical presentation and an initially non-diagnostic biopsy.
All three are alive and thriving because mNGS testing provided answers when traditional diagnostics couldn't.
We're at an inflection point in ID diagnostics.
For over a hundred years, we have relied on finding the bacteria directly, in sputum, in tissue, under the microscope, growing in culture.
It has worked, but it has significant limitations.
mNGS testing represents a paradigm shift:
we're no longer looking for the bacteria themselves, but for the genetic evidence they leave behind.
Permit me to say, It's like the difference between catching a criminal in the act versus identifying them from DNA evidence at the crime scene.
Both are valid. Both have their place.
But sometimes DNA evidence is all you have — and it's enough!
Here's what keeps me up at night: these three patients got mNGS testing and it saved them.
But how many other patients with complex TB presentations don't have access to this technology?
Cost and availability remain barriers. But as the technology becomes more widely adopted and prices decrease, mNGS testing should become part of our standard approach for complex TB cases.
TB diagnosis doesn't always require sputum. mNGS in blood can detect MTB even when respiratory samples aren't available.
Extrapulmonary TB is hard to diagnose. mNGS has higher sensitivity than cultures for TB outside the lungs.
Earlier diagnosis means earlier treatment. mNGS results in days, not weeks.
Culture is still important. You need cultures for drug susceptibility testing, but mNGS can guide initial treatment decisions.
Stay tuned for more Mystery Infection Files — where every case tells a story, and every story carries a lesson.
The details of these cases have been shared to educate healthcare professionals about the emerging role of METAGENOMICS testing as an adjunct diagnostic tool in complex tuberculosis cases where traditional methods face significant limitations.